Ad is loading...
BALFX
Price
$36.50
Change
+$0.12 (+0.33%)
Updated
Nov 22 closing price
MBERX
Price
$32.80
Change
+$0.14 (+0.43%)
Updated
Nov 22 closing price
Ad is loading...

BALFX vs MBERX

Header iconBALFX vs MBERX Comparison
Open Charts BALFX vs MBERXBanner chart's image
American Funds American Balanced F1
Price$36.50
Change+$0.12 (+0.33%)
VolumeN/A
CapitalizationN/A
NYLI Balanced Class R6
Price$32.80
Change+$0.14 (+0.43%)
VolumeN/A
CapitalizationN/A
BALFX vs MBERX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALFX vs. MBERX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a StrongBuy and MBERX is a Buy.

FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 238B vs. MBERX (466M). MBERX pays higher dividends than BALFX: MBERX (2.37) vs BALFX (2.21). BALFX was incepted earlier than MBERX: BALFX (24 years) vs MBERX (7 years). MBERX is a more actively managed with annual turnover of: 313.00 vs. BALFX (171.00). MBERX has a lower initial minimum investment than BALFX: MBERX (0) vs BALFX (250). BALFX annual gain was more profitable for investors over the last year : 21.15 vs. MBERX (17.51). BALFX return over 5 years is better than : 36.63 vs. MBERX (12.93).
BALFXMBERXBALFX / MBERX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years7 years-
Gain YTD15.26011.839129%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets238B466M51,073%
Annual Yield % from dividends2.212.3793%
Returns for 1 year21.1517.51121%
Returns for 3 years12.31-6.55-188%
Returns for 5 years36.6312.93283%
Returns for 10 years51.13N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYM38.782.51
+6.93%
Symbotic
ESLA0.910.02
+2.25%
Estrella Immunopharma
NUE151.921.93
+1.29%
Nucor Corp
SENS0.32-0.01
-2.08%
Senseonics Holdings
ELVN24.54-0.87
-3.42%
Enliven Therapeutics